
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
A view of the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Tom Little | Reuters A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the …